EUVIMEDEUVIMED entdecken
Multizentrische Studie

Outcomes and Survival of Egyptian Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Multicentre Retrospective Study

Eman M F Barakat, Mohamed Kohla, Ahmed Tawheed, Hend Ibrahim Shousha iD, Ehab F Moustafa, Mohamed Said, Hamdy Sayed, Eman Rewisha, Ashraf Omar Abdelaziz iD, Khaled M Abd Elaziz, Mohamed Omar Abdelmalek, Hossam Dabees und 27 weitere

Journal of Viral Hepatitis · 2026

DOI: 10.1111/jvh.70127 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Viral Hepatitis, 2026. Verfasst von Eman M F Barakat und 38 weiteren Autor:innen. Beteiligte Einrichtung: Hepatoma Group, Tropical Medicine Department, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B, Hepatitis B, Chronic. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC) poses significant health challenges globally, particularly in regions with considerable HBV prevalence such as Egypt. Despite immunisation programmes, HBV remains a leading cause of liver cancer in Egypt, often diagnosed at advanced stages, complicating management and worsening prognosis. This retrospective multicentre study included 365 Egyptian patients diagnosed with HBV‐related HCC between February 2007 and July 2023 from six tertiary care centres across Egypt. Clinical, laboratory, tumour characteristics, treatment outcomes and overall survival were collected and analysed. Diagnosis was confirmed according to international guidelines using triphasic CT or dynamic MRI. Treatment responses were assessed using modified RECIST criteria, and survival was analysed using Kaplan–Meier curves. Patients had a median age of 59 years, predominantly male (76.4%), and most (98.4%) presented with cirrhosis at diagnosis. The majority were not receiving antiviral treatment (76.71%) at presentation. Intermediate and advanced BCLC stages (B‐D) comprised over 75% of cases. Trans‐arterial chemoembolization was the primary treatment modality (34.5%), followed by sorafenib (24.1%) and best supportive care (28.8%). Median overall survival was 13.1 months. Independent factors associated with mortality included high ALBI score, positive HBV DNA at diagnosis, and advanced Child–Pugh classification. In conclusion: this study underscores the advanced stage at which HBV‐related HCC is typically diagnosed in Egypt and the resulting poor survival outcomes. Strengthening early detection through surveillance programmes, increasing antiviral therapy coverage and adherence to treatment protocols are critical strategies to enhance patient prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis BHepatitis B, ChronicHumansMaleFemaleRetrospective StudiesMiddle AgedEgyptAgedAdultTreatment OutcomeAntiviral AgentsChemoembolization, TherapeuticSurvival Analysis

Stichwörter der Autor:innen

antiviral therapyhepatitis Bhepatocellular carcinomasurvival

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Hepatoma Group, Tropical Medicine Department, Ain Shams University, Cairo, Egypt.
  • Hepatology and Gastroenterology Department, National Liver Institute, Menoufia University, Menoufia, Egypt.
  • Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
  • Endemic Medicine and Hepato-Gastroenterology Department, Cairo University, Cairo, Egypt.
  • Department of Tropical Medicine and Gastroenterology, Assuit University, Assuit, Egypt.
  • National Medical Institute of Damnhour, Damnhour, Egypt.

ORCID-Profile: Hend Ibrahim Shousha, Ashraf Omar Abdelaziz, Safaa Ragab Askar, Ahmed Ramadan, Mohamed El-Kassas

Zitieren

APA

Barakat, E. M. F., Kohla, M., Tawheed, A., Shousha, H. I., Moustafa, E. F., Said, M., Sayed, H., Rewisha, E., Abdelaziz, A. O., Abd Elaziz, K. M., Abdelmalek, M. O., Dabees, H., El Fouly, A., Elkhateeb, E., Nabeel, M. M., Eltabbakh, M., Riad, A. R., Nasif, A., Abdeen, N., …, & El-Kassas, M. (2026). Outcomes and Survival of Egyptian Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Multicentre Retrospective Study. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70127

Vancouver

Barakat EMF, Kohla M, Tawheed A, Shousha HI, Moustafa EF, Said M, et al. Outcomes and Survival of Egyptian Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Multicentre Retrospective Study. Journal of Viral Hepatitis. 2026. doi:10.1111/jvh.70127

BibTeX
@article{Barakat2026,
  author = {Barakat, Eman M F and Kohla, Mohamed and Tawheed, Ahmed and Shousha, Hend Ibrahim and Moustafa, Ehab F and Said, Mohamed and Sayed, Hamdy and Rewisha, Eman and Abdelaziz, Ashraf Omar and Abd Elaziz, Khaled M and Abdelmalek, Mohamed Omar and Dabees, Hossam and El Fouly, Amr and Elkhateeb, Eman and Nabeel, Mohamed Mahmoud and Eltabbakh, Mohamed and Riad, Ahmed Radwan and Nasif, Anwar and Abdeen, Nermeen and Elhelbawy, Mostafa and Elbaz, Tamer and Askar, Safaa Ragab and Shoukry, Mona and Khalifa, Yosra and Abdelmaksoud, Ahmed Hosni and Shamkh, Mostafa Abd Alfattah and Kaddah, Mona and Abdelrazek, Yasser Arafat and Lithy, Rania and Sleem, Ahmed A and Hashem, Mohamed Bassam and Abdelaziz, Abdelaziz Ahmed and Ramadan, Ahmed and Farid, Hoda M and Abdallah, Nourhan Mohamed and Ghazy, Mohamed Shaker and AbouElmaaty, Mohamed ElGharib and Hassan, Mohammed Sobhi and El-Kassas, Mohamed},
  title = {Outcomes and Survival of Egyptian Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Multicentre Retrospective Study},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  doi = {10.1111/jvh.70127}
}
Kostenlos starten →